Matilde Yañez

3D MI-DRAGON: new model for the reconstruction of US FDA drug- target network and theoretical-experimental studies of inhibitors of rasagiline derivatives for AChE.

Humberto González-Díaz, Xerardo García-Mera, Francisco Prado-Prado, 2012, Current topics in medicinal chemistry.

Brain-inspired cheminformatics of drug-target brain interactome, synthesis, and assay of TVP1022 derivatives

Humberto González-Díaz, Xerardo García-Mera, Nerea Alonso, 2016, Neuropharmacology.

TOPS-MODE model of multiplexing neuroprotective effects of drugs and experimental-theoretic study of new 1,3-rasagiline derivatives potentially useful in neurodegenerative diseases.

Feng Luan, M Natália D S Cordeiro, Humberto González-Díaz, 2013, Bioorganic & medicinal chemistry.

2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins.

Humberto González-Díaz, Pablo Riera-Fernandez, Xerardo García-Mera, 2011, European journal of medicinal chemistry.

Prediction of Multi-Target Networks of Neuroprotective Compounds with Entropy Indices and Synthesis, Assay, and Theoretical Study of New Asymmetric 1,2-Rasagiline Carbamates

Humberto González-Díaz, Francisco J. Prado-Prado, Xerardo García-Mera, 2014, International journal of molecular sciences.

N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine, a new cholinesterase and monoamine oxidase dual inhibitor.

Stefano Alcaro, Katarina Nikolic, Francesco Ortuso, 2014, Journal of medicinal chemistry.

Model for high-throughput screening of multitarget drugs in chemical neurosciences: synthesis, assay, and theoretic study of rasagiline carbamates.

Feng Luan, Humberto González-Díaz, Xerardo García-Mera, 2013, ACS chemical neuroscience.